Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
Guardant Health (GH) reported a Q3 loss of $0.45 per share, beating the Zacks Consensus Estimate of a $0.55 loss. This is an improvement from the $0.73 loss per share a year ago.
November 07, 2024 | 12:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health reported a Q3 loss of $0.45 per share, which is better than the expected loss of $0.55 per share and an improvement from last year's $0.73 loss.
The better-than-expected earnings report and improvement from the previous year suggest positive momentum for Guardant Health, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100